Scalper1 News
Mylan (MYL) was up 3%, near 54, in early trading in the stock market today after the drugmaker beat Q3 estimates late Thursday. Earlier, the stock was up more than 7% at a nearly eight-month high above 56. Earnings came in on the high end of the raised guidance range that Mylan offered on Oct. 3, at $1.16 a share. That was up 41% from the year-earlier quarter and 2 cents higher than analysts’ consensus, according to Thomson Reuters. Sales rose 18% Scalper1 News
Scalper1 News